The MBS Review Taskforce (the Taskforce) commissions clinical reviews to examine MBS items in a particular clinical area, with a view to aligning those items with modern clinical evidence and best practice.
Clinical reviews are often performed by clinical committees, chaired by a clinician practising in the area under review, and comprised of other clinicians, health system experts and consumers. General practitioners participate on all clinical reviews.
Some clinical reviews are conducted by working groups and reference groups. These groups consider targeted clinical issues and can report directly to the Taskforce, or to the Taskforce through a clinical committee.
Recommendations arising from individual clinical reviews are provided to the Taskforce ahead of consultation with impacted stakeholders.
Nominations to participate in a clinical review
Nominations to participate in a clinical review of the MBS are currently closed.
Commenced September 2015
Commenced September 2016
Commenced June 2018
Aboriginal and Torres Strait Islander Health
Mental Health Services
Plastic & Reconstructive Surgery
The Consumer Panel was established in September 2016 to support the Taskforce. The Panel’s work includes providing information, training and support for consumer representatives on MBS Review Clinical Committees. The Consumer Panel will also provide reports and recommendations to the Taskforce about consumer perspectives on the Review.
The Taskforce understands the value that consumer representation has in the review process, providing a critical perspective in the evidence-based review. As such, the MBS Review Taskforce supports on-going consumer representation on not only the Consumer Panel, but also on the MBS Review Taskforce, Principle Committees and Working Groups.
Reviews prior to the MBS Review
A number of previous reviews were completed or in progress under the auspices of the Medical Services Advisory Committee (MSAC). Some of these reviews will be completed under the auspices of the MBS Review Taskforce.